Cargando…
Epilepsy Associates with Decreased HIF-1α/STAT5b Signaling in Glioblastoma
Epilepsy at presentation is an independent favorable prognostic factor in glioblastoma (GBM). In this study, we analyze the oncologic signaling pathways that associate with epilepsy in human GBMs, and that can underlie this prognostic effect. Following ethical approval and patient consent, fresh fro...
Autores principales: | Berendsen, Sharon, Spliet, Wim G. M., Geurts, Marjolein, Van Hecke, Wim, Seute, Tatjana, Snijders, Tom J., Bours, Vincent, Bell, Erica H., Chakravarti, Arnab, Robe, Pierre A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356242/ https://www.ncbi.nlm.nih.gov/pubmed/30621209 http://dx.doi.org/10.3390/cancers11010041 |
Ejemplares similares
-
STAT5b is a marker of poor prognosis, rather than a therapeutic target in glioblastomas
por: Dubois, Nadège, et al.
Publicado: (2022) -
Adverse prognosis of glioblastoma contacting the subventricular zone: Biological correlates
por: Berendsen, Sharon, et al.
Publicado: (2019) -
Effects of valproic acid on histone deacetylase inhibition in vitro and in glioblastoma patient samples
por: Berendsen, Sharon, et al.
Publicado: (2019) -
Tumor-related molecular determinants of neurocognitive deficits in patients with diffuse glioma
por: van Kessel, Emma, et al.
Publicado: (2022) -
Early Surgery Prolongs Professional Activity in IDH Mutant Low-Grade Glioma Patients: A Policy Change Analysis
por: Robe, Pierre A., et al.
Publicado: (2022)